Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.
about
Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and VomitingComparative effectiveness of ramosetron for preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis.Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.
P2860
Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Ramosetron Versus Ondansetron ...... Phase III Trial, KCSG PC10-21.
@ast
Ramosetron Versus Ondansetron ...... Phase III Trial, KCSG PC10-21.
@en
type
label
Ramosetron Versus Ondansetron ...... Phase III Trial, KCSG PC10-21.
@ast
Ramosetron Versus Ondansetron ...... Phase III Trial, KCSG PC10-21.
@en
prefLabel
Ramosetron Versus Ondansetron ...... Phase III Trial, KCSG PC10-21.
@ast
Ramosetron Versus Ondansetron ...... Phase III Trial, KCSG PC10-21.
@en
P2093
P2860
P921
P1433
P1476
Ramosetron Versus Ondansetron ...... Phase III Trial, KCSG PC10-21
@en
P2093
Eun-Kee Song
Hwa Jung Kim
Hyo Jung Kim
Hyun Woo Lee
Jin Seok Ahn
Jin-Hyoung Kang
Joung Soon Jang
Jun Suk Kim
Keon Uk Park
P2860
P304
P356
10.1634/THEONCOLOGIST.2015-0128
P577
2015-10-28T00:00:00Z